{"DataElement":{"publicId":"2681258","version":"1","preferredName":"Donor Cellular Infusion Within Integer::10 Week Performed Total Count","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation._On the inside; contained in._A number with no fractional part.::10._Any period of seven consecutive days._Executed and carried through to completion._the total numeric count of something.","longName":"DCl_WI_INT_WK_TTL_CT","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2681256","version":"1","preferredName":"Donor Cellular Infusion Within Integer::10 Week Performed","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation._On the inside; contained in._A number with no fractional part.::10._Any period of seven consecutive days._Executed and carried through to completion.","longName":"DCl_WI_10_WK_PE","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2793658","version":"1","preferredName":"Donor Cellular Infusion","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.","longName":"C77273","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Donor Cellular Infusion","conceptCode":"C77273","definition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"58D847F5-C148-4B1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-09","modifiedBy":"ONEDATA","dateModified":"2008-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2786892","version":"1","preferredName":"Within Integer::10 Week Performed","preferredDefinition":"On the inside; contained in.:A number with no fractional part.::10:Any period of seven consecutive days.:Performed; carried out.","longName":"C25282:C45255::10:C29844:C3800","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"577DCF76-393E-217A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-09-22","modifiedBy":"ONEDATA","dateModified":"2008-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39F4D181-8128-2009-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-12","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2433953","version":"1","preferredName":"Total Count","preferredDefinition":"the total numeric count of something.","longName":"TTL_CT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207950","version":"1","preferredName":"Total Count","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.:To determine the number or amount of something; the result of this activity.","longName":"C25304:C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3647-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06674CCB-CE3B-04A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-11-28","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964925","version":"1","longName":"2450r1: Post-TED","context":"NHLBI"},{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842913","version":"1","longName":"Best Response","context":"NHLBI"},{"publicId":"2842917","version":"1","longName":"Supportive","context":"NHLBI"}]}],"AlternateNames":[{"name":"post_ted_dci_ttl_gt10wk","type":"NMDP_FN","context":"NHLBI"},{"name":"dci_number_infusions","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"From the date of the first DC","type":"Preferred Question Text","description":"From the date of the first DCI for this grouping, give the total number of DCIs given within 10 weeks.","url":null,"context":"NHLBI"},{"name":"Specify the number of cell infusions given within 10 weeks of the first DCI","type":"Alternate Question Text","description":"Specify the number of cell infusions given within 10 weeks of the first DCI","url":null,"context":"NHLBI"},{"name":"Total # DCI in 10 weeks","type":"Alternate Question Text","description":"Total # DCI in 10 weeks","url":null,"context":"NHLBI"},{"name":"Specify the number of cell infusions given within 10 weeks of the DCI","type":"Alternate Question Text","description":"Specify the number of cell infusions given within 10 weeks of the DCI","url":null,"context":"NHLBI"},{"name":"Specify the total number of cell infusions given within 10 weeks of the DCI","type":"Alternate Question Text","description":"Specify the total number of cell infusions given within 10 weeks of the DCI","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39F4D181-813B-2009-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-12","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-12","modifiedBy":"NYCHM","dateModified":"2010-11-19","changeDescription":"Added alt name 'dci_number_infusions' for 2100 SW 4/7/10.  Added AQT - 11/2/10 SLS. 11/19/10mn-added aqt for 2200 to include 'total'.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}